Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 26, 2024.
All times in Eastern Daylight Time.
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 25.04.2024 FDNU IE00BG0SSC32 1,575,002.00 USD 42... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 25.04.2024 NQCYBREN IE00BF16M727 19,646,888.00... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 25.04.2024 FBTU.LN IE00BL0L0H60 400,002.00 ... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 25.04.2024 FTCS. IE00BL0L0D23 650,002.00 USD 18,31... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 25.04.2024 FVD. IE00BKVKW020 800,002.00 U... more »
-
SLCA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of U.S. Silica Holdings, Inc. Is Fair to ShareholdersNEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of U.S. Silica Holdings, Inc. (NYSE: SLCA) to affiliates of Apollo for $15.50 per share i... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 25.04.2024 FCSG IE00BKPSPT20 85... more »
-
Global Non-meat Ingredients Industry Research 2024-2029: Technological Advancements to Develop New Product Lines, Growth of Indian Processed Market, & Rising Demand from Fast-Food Chains - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Global Non-meat Ingredients Market by End-Use Applications (Fresh Meat, Processed and Cured Meats, Marinated, Ready-To-Eat Meat Products, Frozen Meat Products, and Con... more »
-
IperionX Titanium HAMR Furnace Installation CompleteCHARLOTTE, N.C.--(BUSINESS WIRE)--IPERIONX TITANIUM HAMR FURNACE INSTALLATION COMPLETE more »
-
ATLANTA--(BUSINESS WIRE)--Manhattan wins Overall Innovation of the Year award by RetailTech Breakthrough for it's latest offering, Fulfillment Experience Insights. more »
-
Cheniere Declares Quarterly DividendHOUSTON--(BUSINESS WIRE)--Cheniere Declares Quarterly Dividend more »
-
Premier, Inc. Declares Quarterly Cash DividendCHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $... more »
-
Bio-Rad Announces Life Science Group Management ChangesHERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of Jam... more »
-
Align Technology Announces $150 Million Open Market RepurchaseTEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners... more »
-
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal CancerOSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rec... more »